Status:
RECRUITING
A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency
Lead Sponsor:
Pascoe Pharmazeutische Praeparate GmbH
Conditions:
Deficiency, Vitamin C
Chronic Disease
Eligibility:
All Genders
18-120 years
Brief Summary
The goal of this observational study is to learn more about the disease and the symptoms where the product will use and in which patient groups. Further on, it is interesting to know clinical pictures...
Detailed Description
The aim of this long-term observational study is to document the use of Vitamin C Injektopas® 7.5g in patients with vitamin C deficiency. The deficiency condition can be diagnosed either by laboratory...
Eligibility Criteria
Inclusion
- Patients with vitamin C deficiency
- Age ≥ 18 years
Exclusion
- Hypersensitivity to the active ingredient or any of the excipients
- Oxalate urolithiasis
- Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion
- Renal insufficiency
- Glucose-6-phosphate dehydrogenase deficiency/defect
- Pregnant/breastfeeding women
Key Trial Info
Start Date :
January 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 14 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06983847
Start Date
January 12 2019
End Date
November 14 2028
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Physicians from Austria
Vienna, Etc., Austria, Austria